RecruitingNCT06620627

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (PROCEED-CRC)


Sponsor

Natera, Inc.

Enrollment

5,000 participants

Start Date

Jan 26, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples from people who are already scheduled for a routine screening colonoscopy, in order to develop and test a new early cancer detection blood test (a liquid biopsy screening assay). The goal is to see whether a blood test can detect early colorectal cancer or precancerous growths before they show symptoms. **You may be eligible if...** - You are 40 years of age or older - You are planning to undergo a routine, asymptomatic (screening) colonoscopy — meaning you have no symptoms - You are able to tolerate having blood drawn for research - You can provide blood samples within 120 days before your colonoscopy - You have not had a colonoscopy in the recent past (per study criteria) **You may NOT be eligible if...** - You have any prior history of cancer (except skin basal cell or squamous cell cancer removed at least 12 months ago) - You had a complete colonoscopy recently (within the required timeframe) - You have symptoms that prompted the colonoscopy (this is only for asymptomatic screening) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Natera

Austin, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06620627


Related Trials